Resultados de la búsqueda 11-20 of 14684 for Severe hypertriglyceridaemia

1. Enfermedad de las arterias coronarias.

   A critical review of chronic kidney disease as a risk factor for coronary artery disease. International Journal of Cardiology: Heart & Vasculature. 2021; ...

2. Cirugía - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to follow Mayo Clinic patients with severe brachial plexus injuries who underwent upper limb amputation. A Study to Evaluate a ...

3. Prophylactic Table ID File.indd

   Page 1.

4. Hematología - Ensayos clínicos - Mayo Clinic

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

5. Hematología - Ensayos clínicos - Mayo Clinic

   This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

6. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

   As the global epidemic of obesity and diabetes mellitus spreads, an exponential rise in incident chronic kidney disease (CKD) complicated by end stage renal ...

7. Hematología - Ensayos clínicos - Mayo Clinic

   Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia. The Impact of a Geriatric ...

8. Untitled

   Page 1.

9. Hematología - Ensayos clínicos - Mayo Clinic

   This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...